COMP <GO>
BNR vs XGN // REVENUE GROWTH (YOY)
Burning Rock Biotech Limited (NASDAQ) VS. Exagen Inc. (NASDAQ) • 15-METRIC TALLY: BNR 5
— XGN 3
▲ REVENUE GROWTH (YOY) LEADER: XGN
LAST: $11.05 (-9.87%) • MKT CAP: $116.5M
revenue-growth
9.20%
LAST: $8.70 (+3.57%) • MKT CAP: $210.8M
revenue-growth
19.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNR VS. XGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BNR | XGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.70% | 58.30% | +16.40 | BNR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.14% | -6.77% | +2.63 | BNR | /fcf-yield <GO> |
| Operating Margin | -10.20% | -21.10% | +10.90 | BNR | /operating-margins <GO> |
| Net Profit Margin | -10.30% | -30.00% | +19.70 | BNR | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 9.20% | 19.70% | -10.50 | XGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 4/9 | +1.00 | BNR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.1 | 59.9 | -20.80 | XGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $116.5M | $210.8M | -$94.2M | XGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BNR REV | XGN REV | BNR GROSS % | XGN GROSS % | BNR FCF | XGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $77.2M | $66.6M | 74.7% | 58.3% | -$4.8M | -$14.3M |
| FY 2024 | $70.7M | $55.6M | 70.3% | 59.5% | -$13.4M | -$13.8M |
| FY 2023 | $75.7M | $52.5M | — | — | -$36.0M | -$14.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNR // BETA —
XGN // BETA —